B

Bionomics Limited
D

BNOX

0.29000
USD
-0.00
(-1.56%)
Market Closed
Volume
6,520
EPS
-3
Div Yield
-
P/E
-0
Market Cap
5,662,931
News

Title: Bionomics Limited

Sector: Healthcare
Industry: Biotechnology
Bionomics Ltd is a clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.